Back to CC Overview
NYQ · Valuation Lab
CC
The Chemours Company
Last$14.58
Market cap2.2B
EV/EBITDA11.0x
Intrinsic value
$6.82
MoS -113.8% · Overvalued
Assuming 3.7% FCF margin and 1.0% Y1–5 growth.
Upside to price
EV (DCF)4.9B
Terminal share66%
Expected IV$15.85
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 66% of EV
PV of stage FCFs1.6B
PV of terminal value3.2B
Enterprise value4.9B
Net cash / (debt)-3.8B
Equity value1B
Intrinsic value / share$6.82
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 5.9B | 217.5M | 203.9M | 93.7% |
| Y2 | 5.9B | 219.7M | 193.1M | 87.9% |
| Y3 | 6B | 221.9M | 182.8M | 82.4% |
| Y4 | 6.1B | 224.1M | 173.1M | 77.2% |
| Y5 | 6.1B | 226.4M | 163.9M | 72.4% |
| Y6 | 6.2B | 230.9M | 156.7M | 67.9% |
| Y7 | 6.4B | 235.5M | 149.9M | 63.6% |
| Y8 | 6.5B | 240.2M | 143.3M | 59.7% |
| Y9 | 6.6B | 245M | 137M | 55.9% |
| Y10 | 6.8B | 249.9M | 131M | 52.4% |
| Terminal | — | — | 3.2B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.